Wednesday, May 28, 2008

FAA Bans Anti-Smoking Drug Chantix Due To Side Effects

Washington (ChattahBox) - A report from the non-profit group the Institute for Safe Medication Practices has caused the Federal Aviation Administration (FAA) to ban the use of Pfizer’s anti-smoking drug Chantix for pilots and air traffic controllers.

The report cites major physical side effects with the anti-smoking drug from Pfizer, Chantix including dizziness, seizures, spasms, and loss of consciousness. Over 170 accidental injuries were cited in the report.

The non-profit group cited major concerns in their report “about the use of Chantix among persons operating aircraft, trains, buses and other vehicles, or in other settings where a lapse in alertness or motor control could lead to massive, serious injury.”

The FAA put the ban on the use of the drug into effect immediately.
Pfizer has come to the defense of Chantix, stating “It is important to understand the limitations of spontaneous adverse event reporting. Often these reports lack sufficient medical information and/or have confounding factors that prevent a meaningful assessment of causality.”